206 related articles for article (PubMed ID: 9498160)
21. [Cytogenetic and molecular aspects of Ph-positive leukemia].
Misawa S; Nishigaki H
Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072
[TBL] [Abstract][Full Text] [Related]
22. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
Alimena G; Breccia M; Latagliata R; Carmosino I; Russo E; Biondo F; Diverio D; Mancini M; Nanni M; Mandelli F
Cancer; 2006 Sep; 107(5):1008-13. PubMed ID: 16878324
[TBL] [Abstract][Full Text] [Related]
23. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
24. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and molecular biological study of Ph positive acute leukemia: comparison with blast crisis of chronic myelogenous leukemia and Ph negative acute lymphoblastic leukemia].
Okada S; Shimizu T; Harada H; Miyoshi Y; Mori H; Niikura H; Omine M; Fujita K; Terada H
Rinsho Ketsueki; 1992 May; 33(5):646-54. PubMed ID: 1630016
[TBL] [Abstract][Full Text] [Related]
26. Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.
Reid AG; De Melo VA; Elderfield K; Clark I; Marin D; Apperley J; Naresh KN
Leuk Res; 2009 Mar; 33(3):418-25. PubMed ID: 18760473
[TBL] [Abstract][Full Text] [Related]
27. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
[TBL] [Abstract][Full Text] [Related]
28. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
Ganessan K; Goel R; Kumar K; Bakhshi S
Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
[TBL] [Abstract][Full Text] [Related]
29. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
Kantarjian H; O'Brien S; Cortes J; Giles F; Thomas D; Kornblau S; Shan J; Beth Rios M; Keating M; Freireich E; Talpaz M
Cancer; 2003 Jul; 98(1):81-5. PubMed ID: 12833459
[TBL] [Abstract][Full Text] [Related]
30. Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation.
Apfelbeck U; Hoefler G; Neumeister P; Fonatsch C; Linkesch W; Sill H
Bone Marrow Transplant; 2000 Nov; 26(10):1111-2. PubMed ID: 11108312
[TBL] [Abstract][Full Text] [Related]
31. Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).
Jehn U; Mittermüller J; Greither L; Clemm C; Heinemann V; Lorenz T; Gross HJ
Anticancer Res; 1989; 9(6):1721-3. PubMed ID: 2627124
[TBL] [Abstract][Full Text] [Related]
32. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
[TBL] [Abstract][Full Text] [Related]
33. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
[TBL] [Abstract][Full Text] [Related]
34. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
35. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
37. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
Sureda A; Carrasco M; de Miguel M; Martínez JA; Conde E; Sanz MA; Díaz-Mediavilla J; Sierra J
Haematologica; 2003 Nov; 88(11):1213-20. PubMed ID: 14607749
[TBL] [Abstract][Full Text] [Related]
38. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
Kolenova A; Maloney KW; Hunger SP
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
[TBL] [Abstract][Full Text] [Related]
39. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
Smith MR; Mohamed AN; Karanes C
Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
[TBL] [Abstract][Full Text] [Related]
40. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
